The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
39 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,754,547 in first-year total cost, median $46,329.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-U (M1)]23
- Special Emphasis Panel[ZCA1 RTRB-Z (M2)]16
Most frequent institutions
- EMORY UNIVERSITY2
- SLOAN-KETTERING INST CAN RESEARCH2
- VAN ANDEL RESEARCH INSTITUTE2
- VIRGINIA COMMONWEALTH UNIVERSITY2
- CASE WESTERN RESERVE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Uncovering Novel Protease Substrates and Inhibitors to Modulate Pyroptosis and Prevent Cancer Progression1F99CA305522-01 | TSAMOURI, LYDIA PARASKEVI | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $51,038 | ZCA1 |
| 2025 | Uncovering immune network principles driving humoral immunity in inflammatory conditions1F99CA305580-01 | BILANOVIC, JANA | ROCKEFELLER UNIVERSITY, NY | $51,038 | ZCA1 |
| 2025 | Spatiotemporal Profiling of the Tumor Immune Microenvironment1F99CA305569-01 | REYNOLDS, DAVID E | UNIVERSITY OF PENNSYLVANIA, PA | $51,038 | ZCA1 |
| 2025 | Interrogating drivers of plasticity in early lung cancer tumorigenesis and metastatic dormancy.1F99CA305568-01 | KRAUSE, KLAVDIJA | SLOAN-KETTERING INST CAN RESEARCH, NY | $51,038 | ZCA1 |
| 2025 | Engineering CD4+ T cells to develop a novel immunotherapy for pancreatic cancer1F99CA305563-01 | GEITGEY, DELANEY KATE | EMORY UNIVERSITY, GA | $51,038 | ZCA1 |
| 2025 | The impact of APOBEC3A-mediated mutagenesis on gene regulation in cancer1F99CA305560-01 | DEWEERD, RACHEL | WASHINGTON UNIVERSITY, MO | $51,038 | ZCA1 |
| 2025 | Targeting mechanisms of chromatin plasticity to improve the efficacy of epigenetic solid tumor therapy1F99CA305570-01 | LIU, YANQING | VAN ANDEL RESEARCH INSTITUTE, MI | $50,038 | ZCA1 |
| 2025 | Interrogating the role of BLTP3A in organizing protective immunity in ovarian cancer1F99CA305528-01 | HOSSEINI, ELAHEH S. | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $48,759 | ZCA1 |
| 2025 | From T Cells to Dendritic Cells: Mechanistic Dissection of CTLA4 and TIM3 in Cancer Immunity1F99CA305515-01 | ZHANG, JIBIN | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $47,096 | ZCA1 |
| 2025 | Transposable Element Regulation and Expression During Cancer Progression1F99CA305585-01 | WALKER, REDDICK | GEORGE WASHINGTON UNIVERSITY, DC | $46,329 | ZCA1 |
| 2025 | Reprogramming Liver Macrophages for Sex-based Hepatocellular Carcinoma Immunotherapy1F99CA305526-01 | SAHA, SUMIT | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $45,660 | ZCA1 |
| 2025 | Evaluating the role of the tumor macroenvironment in cancer cachexia1F99CA305566-01 | ARREOLA, ALEX | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $44,158 | ZCA1 |
| 2025 | Replication Gap Suppression by Translesion Synthesis Promotes Drug Resistance in hard-to-treat cancers1F99CA305484-01 | SEWILAM, REHAM | UNIV OF ARKANSAS FOR MED SCIS, AR | $41,511 | ZCA1 |
| 2025 | Elucidating the role of circPMS1 in melanoma metastasis.1F99CA305524-01 | MECOZZI, NICOL | UNIVERSITY OF SOUTH FLORIDA, FL | $41,251 | ZCA1 |
| 2025 | Modulation of intracellular lipid access by ATGL determines ferroptosis sensitivity in castration-resistant prostate cancer1F99CA305489-01 | CAO, PHAM HONG ANH | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $39,203 | ZCA1 |
| 2025 | Discovery of the mechanisms governing Natural Killer T-cell activation and therapeutic potential in cancer1F99CA305428-01 | VITALE, TEVIS J. | HARVARD MEDICAL SCHOOL, MA | $39,113 | ZCA1 |
| 2024 | The Role of Guanine Exchange Factors in Pancreatic Ductal Adenocarcinoma (PDAC)1F99CA294132-01 | BANNOURA, SAHAR | WAYNE STATE UNIVERSITY, MI | $50,474 | ZCA1 |
| 2024 | Discovery of Novel Therapeutic Strategies for Cancer Immunotherapy1F99CA294168-01 | YANG, XUAN | YALE UNIVERSITY, CT | $50,474 | ZCA1 |
| 2024 | Return-to-work issues in healthcare workers diagnosed with cancer: Investigation and Intervention Development1F99CA294268-01 | YOU, KAI-LIN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $50,474 | ZCA1 |
| 2024 | Identifying and Targeting Drivers of Impaired Translation in Tumor-infiltrating CD8+ T-cells.1F99CA294267-01 | CHEN, YAN-TING | SLOAN-KETTERING INST CAN RESEARCH, NY | $50,474 | ZCA1 |
| 2024 | Human papillomavirus mRNA detection for assessing cervical cancer risk in resource-limited settings1F99CA294262-01 | NOVAK, EMILIE NEWSHAM | RICE UNIVERSITY, TX | $50,474 | ZCA1 |
| 2024 | An In-depth Examination of Psychological Distress among Black Breast Cancer Survivors1F99CA294259-01 | TARIQ, FARIHA | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $50,474 | ZCA1 |
| 2024 | Dissecting the genetic basis of cancer immune evasion in squamous cell carcinoma1F99CA294257-01 | NICHOLSON, BENJAMIN | UNIVERSITY OF CHICAGO, IL | $50,474 | ZCA1 |
| 2024 | Investigating the molecular signatures and pathways indicative of air pollution toxicity in lung carcinogenesis using single- and multi-omics analyses of genomics, proteomics, and metabolomics1F99CA294242-01 | TANG, ZIYIN | EMORY UNIVERSITY, GA | $50,474 | ZCA1 |
| 2024 | Determinants of susceptibility to pediatric acute myeloid leukemia1F99CA294248-01 | HARMON, LAUREN MARIE | VAN ANDEL RESEARCH INSTITUTE, MI | $49,474 | ZCA1 |
| 2024 | Understanding expression and signaling of sex hormone receptors in brain cancers1F99CA294312-01 | DWYER CADY, MARTHA ADDISON | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $48,717 | ZCA1 |
| 2024 | Resolving epigenetic determinants of cellular plasticity programs in non-small cell lung cancer1F99CA294252-01 | PATEL, AYUSHI | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $43,550 | ZCA1 |
| 2024 | Microbiome-Mitochondrial Interactions Driving Cancer-Induced Cachexia in the Obese State1F99CA294251-01 | CARDACI, THOMAS | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA, SC | $40,199 | ZCA1 |
| 2024 | Investigating the Microenvironmental Dysregulation and Polypharmacy Impact during Acute Myeloid Leukemia in an in vitro model of the human bone marrow and in vivo models.1F99CA294129-01 | SHARIPOL, AZMEER | UNIVERSITY OF ROCHESTER, NY | $39,957 | ZCA1 |
| 2024 | The alterations caused by obese extracellular vesicles on colorectal cancer tumor microenvironment1F99CA294247-01 | HAQUE, PARSA | UNIVERSITY OF COLORADO DENVER, CO | $39,872 | ZCA1 |
| 2024 | Integrative Deep Learning Models for Multimodal Markers of Cancer Treatment Outcomes1F99CA294169-01 | KREBS, OLIVIA | CASE WESTERN RESERVE UNIVERSITY, OH | $39,869 | ZCA1 |
| 2024 | Ceramide and Cell Metabolism: Defining the Role of Sphingolipids in Modulating Mitochondrial Bioenergetics of Chronic Lymphocytic Leukemia1F99CA294256-01 | VASS, LUKE REMINGTON | UNIVERSITY OF VIRGINIA, VA | $39,698 | ZCA1 |
| 2024 | Tumor-cell intrinsic and extrinsic determinants of drug resistance and metastasis1F99CA294241-01 | PRIMEAUX, MARK | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $38,693 | ZCA1 |
| 2024 | Data-driven Diagnostics using Multimodal- AI Assisted Approaches for Early Cancer Detection1F99CA294164-01 | VILLARREAL, PAULA | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $38,383 | ZCA1 |
| 2024 | Comparing post-test genetic counseling with and without pre-test counseling: The evolving landscape for optimizing cancer care1F99CA294165-01 | BROADBRIDGE, ELIZABETH | RUTGERS, THE STATE UNIV OF N.J., NJ | $38,154 | ZCA1 |
| 2024 | The interface of neurons and cancer1F99CA294269-01 | LUKASIK, KIMBERLY | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $38,079 | ZCA1 |
| 2024 | PD-1 blockade effects on bone strength and metastatic progression1F99CA294171-01 | JOSEPH, GWENYTH JEAN | VANDERBILT UNIVERSITY, TN | $35,870 | ZCA1 |
| 2024 | Harnessing Extracellular Vesicles to Overcome Radiation Resistance in Pediatric Diffuse Midline Glioma1F99CA294265-01 | OZA, VIRAL | UNIVERSITY OF KENTUCKY, KY | $35,602 | ZCA1 |
| 2024 | Metabolic Reprogramming of Myeloid Cells to Enhance Cancer Immunotherapy1F99CA294065-01 | MORREALE, BRIAN GEORGE | ROSWELL PARK CANCER INSTITUTE CORP, NY | $35,292 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.